Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

STAAR Surgical Company - Common Stock (NQ:STAA)

25.80 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 15, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about STAAR Surgical Company - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
11 12 Next >
3 Stocks Under $50 in Hot Water
The $10-50 price range often includes mid-sized businesses with proven track records and plenty of growth runway ahead. They also usually carry less risk than penny stocks, though they’re not immune to... 
Via StockStory
A Look Back at Medical Devices & Supplies - Specialty Stocks’ Q3 Earnings: STAAR Surgical (NASDAQ:STAA) Vs The Rest Of The Pack
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at STAAR Surgical (NASDAQ:STAA) and the best... 
Via StockStory
STAAR Surgical Announces Leadership Transition
From STAAR Surgical Company
Via Business Wire
STAA Investors Have Opportunity to Join STAAR Surgical Company Fraud Investigation with the Schall Law Firm
From The Schall Law Firm
Via Business Wire
Analyst Expectations For Staar Surgical's Future
 
Via Benzinga
Why NASDAQ:STAA Is a Promising High-Growth Stock in the Midst of Consolidation.
Is STAAR SURGICAL CO (NASDAQ:STAA) on the Verge of a Major Breakout as a Strong Growth Stock? 
Via Chartmill
Keep an eye on the top gainers and losers in Wednesday's session.
Keep an eye on the top gainers and losers in Wednesday's session, as they reflect the most notable price movements. 
Via Chartmill
Let's have a look at the top gainers and losers in the middle of the day of today's session.
Here are the top movers in Wednesday's session, showcasing the stocks with significant price changes. 
Via Chartmill
Eye Lens Maker Staar Surgical Stock Sinks As Sales Drop To $49 Million, Analyst Downgrades
Staar Surgical posted a Q4 2024 revenue decline due to weak China sales. The company plans cost-cutting measures. 
Via Benzinga
This PPG Industries Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday
 
Via Benzinga
NASDAQ:STAA, a growth stock which is not overvalued.
Despite its growth, STAAR SURGICAL CO (NASDAQ:STAA) remains within the realm of affordability. 
Via Chartmill
Despite its growth, NASDAQ:STAA remains within the realm of affordability.
STAAR SURGICAL CO (NASDAQ:STAA), a growth stock which is not overvalued. 
Via Chartmill
In the world of growth stocks, NASDAQ:STAA shines as a value proposition.
Investors should take note of NASDAQ:STAA, a growth stock that remains attractively priced. 
Via Chartmill
Teradata Posts Weak Revenue, Joins Lyft, Vertiv, Zillow And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
 
Via Benzinga
Why Upstart Shares Are Trading Higher By Over 25%; Here Are 20 Stocks Moving Premarket
 
Via Benzinga
Which stocks are moving after the closing bell on Tuesday?
Let's have a look at what is happening on the US markets after the closing bell on Tuesday. Below you can find the top gainers and losers in today's after hours session. 
Via Chartmill
Exploring Staar Surgical's Earnings Expectations
 
Via Benzinga
Investors seeking growth at a reasonable cost should explore NASDAQ:STAA.
Looking for growth without the hefty price tag? Consider STAAR SURGICAL CO (NASDAQ:STAA). 
Via Chartmill
STAAR Surgical Reports Fourth Quarter and Fiscal Year 2024 Results
From STAAR Surgical Company
Via Business Wire
Don't overlook NASDAQ:STAA—a stock with solid growth prospects and a reasonable valuation.
STAAR SURGICAL CO was identified as a growth stock that isn't overvalued. NASDAQ:STAA is excelling in various growth indicators while maintaining a solid financial footing. 
Via Chartmill
STAAR Surgical to Host Fourth Quarter and Fiscal Year 2024 Earnings Conference Call and Webcast on February 19, 2025
From STAAR Surgical Company
Via Business Wire
Morgan Stanley Maintains Positive MedTech Outlook Despite Setbacks in 2024, Upgrades Intuitive Surgical And Stryker, Downgrades Nevro And Glaukos
Morgan Stanley upgrades key MedTech stocks, highlighting strong demand and growth potential, while downgrading others amid company-specific challenges. 
Via Benzinga
Analyst Scoreboard: 4 Ratings For Staar Surgical
 
Via Benzinga
Investors should take note of NASDAQ:STAA, a growth stock that remains attractively priced.
Investors seeking growth at a reasonable cost should explore STAAR SURGICAL CO (NASDAQ:STAA). 
Via Chartmill
STAAR Surgical to Participate in BTIG Ophthalmology Day
From STAAR Surgical Company
Via Business Wire
STAAR Surgical to Participate in Stephens Annual Investment Conference (NASH2024)
From STAAR Surgical Company
Via Business Wire
CORRECTING and REPLACING STAAR Surgical Reports Third Quarter 2024 Results
From STAAR Surgical Company
Via Business Wire
STAAR Surgical to Report Third Quarter Results on October 30, 2024
From STAAR Surgical Company
Via Business Wire
STAAR Surgical Experience Center Expands to Meet Growing Surgeon Demand
From STAAR Surgical Company
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9
...
11 12 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.